From the Journals
AI-Supported Mammography in MASAI Study
-
By
February 2, 2026
-
3 min
-
1
AI reduces interval cancer rates by 12%.
-
2
Study involved 105,934 women.
-
3
Median age of participants was 54 years.
-
4
AI sensitivity was 80.5%, higher than 73.8% in controls.
-
5
Screen workload decreased by 44%.
-
6
Fewer invasive tumors were detected with AI.
-
7
Conducted from April 2021 to December
-
8
Funded by Swedish Cancer Society.
-
The MASAI study shows that AI-supported mammography screening significantly reduces interval cancer rates by 12% and enhances detection sensitivity over traditional double reading methods, making it a viable option to mitigate challenges due to radiologist shortages. Conducted from April 2021 to December 2022, it involved 105,934 women assigned to either AI or control groups. Results indicated fewer invasive and larger tumors in the AI group, with an improved sensitivity of 80.5%. Researchers advocate for further studies on cost-effectiveness in real-world applications.
-
1
AI reduces interval cancer rates by 12%.
-
2
Study involved 105,934 women.
-
3
Median age of participants was 54 years.
-
4
AI sensitivity was 80.5%, higher than 73.8% in controls.
-
5
Screen workload decreased by 44%.
-
6
Fewer invasive tumors were detected with AI.
-
7
Conducted from April 2021 to December
-
8
Funded by Swedish Cancer Society.
Listen Tab content
